Pharmacokinetics and tissue distribution of ginsenoside Rh2 and Rg3 epimers after oral administration of BST204, a purified ginseng dry extract, in rats

References

• Bae EA, Han MJ, Choo MK, et al. (2002). Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biol Pharm Bull 25:58–63
   PubMed Web of Science ®Google Scholar
• Bae SH, Zheng YF, Yoo YH, et al. (2013). Stereoselective determination of ginsenosides Rg3 and Rh2 epimers in rat plasma by LC-MS/MS: application to a pharmacokinetic study. J Sep Sci 36:1904–12
   PubMedGoogle Scholar
• Fei XF, Wang BX, Tashiro S, et al. (2002). Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells. Acta Pharmacol Sin 23:315–22
   PubMed Web of Science ®Google Scholar
• Gao JL, Lv GY, He BC, et al. (2013). Ginseng saponin metabolite 20(S)-protopanaxadiol inhibits tumor growth by targeting multiple cancer signaling pathways. Oncol Rep 30:292–8
   PubMed Web of Science ®Google Scholar
• Gu Y, Wang GJ, Sun JG, et al. (2009). Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs. Food Chem Toxicol 47:2257–68
   PubMed Web of Science ®Google Scholar
• Gu Y, Wang GJ, Sun JG, et al. (2006). Quantitative determination of ginsenoside Rh2 in rat biosamples by liquid chromatography electrospray ionization mass spectrometry. Anal Bioanal Chem 386:2043–53
   PubMed Web of Science ®Google Scholar
• Gu Y, Wang GJ, Wu XL, et al. (2010). Intestinal absorption mechanisms of ginsenoside Rh2: stereoselectivity and involvement of ABC transporters. Xenobiotica 40:602–12
   PubMed Web of Science ®Google Scholar
• Helms S. (2004). Cancer prevention and therapeutics: panax ginseng. Altern Med Rev 9:259–74
   PubMedGoogle Scholar
• Keum YS, Han SS, Chun KS, et al. (2003). Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-κB activation and tumor promotion. Mutat Res 523--524:75–85
   PubMedGoogle Scholar
• Kim HS, Lee EH, Ko SR, et al. (2004). Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharm Res 27:429–35
   PubMed Web of Science ®Google Scholar
• Kim SW, Kwon HY, Chi DW, et al. (2003). Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg3. Biochem Pharmacol 65:75–82
   PubMed Web of Science ®Google Scholar
• Kitagawa I, Yoshikawa M, Yoshihara M, et al. (1983). Chemical studies on crude drug precession: 1. The constituents of ginseng radix rubra. Yakugaku Zasshi 103:612–22
   PubMed Web of Science ®Google Scholar
• Lee YJ, Kim HY, Kang KS, et al. (2008). The chemical and hydroxyl radical scavenging activity changes of ginsenoside-Rb1 by heat processing. Bioorg Med Chem Lett 18:4515–20
   PubMed Web of Science ®Google Scholar
• Liu H, Yang J, Du F, et al. (2009). Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats. Drug Metab Dispos 37:2290–8
   PubMed Web of Science ®Google Scholar
• Liu J, Shimizu K, Yu H, et al. (2010). Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells. Fitoterapia 81:902–5
   PubMedGoogle Scholar
• Liu J, Shiono J, Shimizu K, et al. (2009). 20(R)-ginsenoside Rh2, not 20(S), is a selective osteoclastgenesis inhibitor without any cytotoxicity. Bioorg Med Chem Lett 19:3320–3
   PubMed Web of Science ®Google Scholar
• Park JA, Lee KY, Oh YJ, et al. (1997). Activation of caspase-3 protease via aBcl-2-insensitive pathway during the process of ginsenoside Rh2-induced apoptosis. Cancer Lett 121:73–81
   PubMed Web of Science ®Google Scholar
• Popovich DG, Kitts DD. (2002). Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line. Arch Biochem Biophys 406:1–8
   PubMed Web of Science ®Google Scholar
• Qi LW, Wang CZ, Yuan CS. (2010). American ginseng: potential structure–function relationship in cancer chemoprevention. Biochem Pharmacol 80:947–54
   PubMed Web of Science ®Google Scholar
• Qi LW, Wang CZ, Yuan CS. (2011). Ginsenosides from American ginseng: chemical and pharmacological diversity. Phytochemistry 72:689–99
   PubMed Web of Science ®Google Scholar
• Qian T, Cai Z, Wong RN, et al. (2005). In vivo rat metabolism and pharmacokinetic studies of ginsenoside Rg3. J Chromatogr B Analyt Technol Biomed Life Sci 816:223–32
   PubMedGoogle Scholar
• Seo JY, Lee JH, Kim NW, et al. (2005a). Effect of a fermented ginseng extract, BST204, on the expression of cyclooxygenase-2 in murine macrophages. Int Immunopharmacol 5:929–36
   PubMed Web of Science ®Google Scholar
• Seo JY, Lee JH, Kim NW, et al. (2005b). Inhibitory effects of a fermented ginseng extract, BST204, on the expression of inducible nitric oxide synthase and nitric oxide production in lipopolysaccharide-activated murine macrophages. J Pharm Pharmacol 57:911–18
   PubMedGoogle Scholar
• Tawab MA, Bahr U, Karas M, et al. (2003). Degradation of ginsenosides in humans after oral administration. Drug Metab Dispos 31:1065–71
   PubMed Web of Science ®Google Scholar
• Wang Z, Zheng Q, Liu K, et al. (2006). Ginsenoside Rh2 enhances antitumour activity and decreases genotoxic effect of cyclophosphamide. Basic Clin Pharmacol Toxicol 98:411–15
   PubMedGoogle Scholar
• Wei X, Chen J, Su F, et al. (2012a). Stereospecificity of ginsenoside Rg3 in promotion of the immune response to ovalbumin in mice. Int Immunol 24:465–71
   PubMed Web of Science ®Google Scholar
• Wei X, Su F, Su X, et al. (2012b). Stereospecific antioxidant effects of ginsenoside Rg3 on oxidative stress induced by cyclophosphamide in mice. Fitoterapia 83:636–42
   PubMedGoogle Scholar
• Xia LJ, Han R. (1996). Differentiation of B16 melanoma cells induced by ginsenoside Rh2. Acta Pharm Sin 31:742–5
   Google Scholar
• Yang H, Yoo G, Kim HS, et al. (2012). Implication of the stereoisomers of ginsenoside derivatives in the antiproliferative effect of HSC-T6 cells. J Agric Food Chem 60:11759–64
   PubMedGoogle Scholar
• Zeng XL, Tu ZG. (2004). Effect of telomerase on ginsenoside Rh2-induced differentiation of hepatocarcinoma cell line SMMC-7721. Chin J Cancer 23:1655–9
   Google Scholar
• Zhang C, Yu H, Hou J. (2011). Effects of 20 (S)-ginsenoside Rh2 and 20 (R)-ginsenoside Rh2 on proliferation and apoptosis of human lung adenocarcinoma A549 cell. Zhongguo Zhong Yao Za Zhi 36:1670–4
   PubMedGoogle Scholar
• Zhang J, Zhou F, Niu F, et al. (2012). Stereoselective regulations of P-glycoprotein by ginsenoside Rh2 epimers and the potential mechanisms from the view of pharmacokinetics. PLoS One 7:e35768
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhou F, Wu X, et al. (2010). 20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: a case for herb–drug interactions. Drug Metab Dispos 38:2179–87
   PubMed Web of Science ®Google Scholar
• Zhao Y, Su S. (2003). Study on anti-tumor activity of Ginsenoside Rh2. Chin J Microbiol 23:61–3
   Google Scholar